GAD autoantibody affinity in schoolchildren from the general population

Diabetologia

Volumn 57, Issue 9, 2014, Pages 1911-1918

  Bender, Christine ^a   Schlosser, Michael ^b   Christen, Urs ^a   Ziegler, Anette G ^c,d   Achenbach, Peter ^c,d  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Affinity; GAD autoantibodies; General population; Schoolchildren; Type 1 diabetes risk

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DRB1 ANTIGEN; IODINE 125; AUTOANTIBODY; GAD AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; SULFUR 35; UNCLASSIFIED DRUG; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CHIMERA; CLINICAL ARTICLE; FOLLOW UP; GENOTYPE; HLA TYPING; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; ALLELE; AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; BINDING ASSAY; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GERMANY; MAJOR CLINICAL STUDY; MALE; ADOLESCENT; IMMUNOLOGY; METABOLISM;

ADOLESCENT; AUTOANTIBODIES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE;

EID: 84905579550     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3294-9     Document Type: Article

References (33)

1. Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293-1300
2. Castano L, Eisenbarth GS (1990) Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647-679
3. Stadinski B, Kappler J, Eisenbarth GS (2010) Molecular targeting of islet autoantigens. Immunity 32:446-456
4. Wenzlau JM, Juhl K, Yu L, et al. (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 104:17040-17045
5. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229
6. Kimpimaki T, Kulmala P, Savola K, et al. (2002) Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87:4572-4579
7. Parikka V, Nanto-Salonen K, Saarinen M, et al. (2012) Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 55:1926-1936
8. Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460-468
9. Bingley PJ (2010) Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 95:25-33
10. Ziegler AG, Rewers M, Simell O, et al. (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309:2473-2479
11. Howson JM, Stevens H, Smyth DJ, et al. (2011) Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 60:2635-2644
12. Achenbach P, Warncke K, Reiter J, et al. (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384-392
13. Hoppu S, Ronkainen MS, Kulmala P, Akerblom HK, Knip M (2004) GAD65 antibody isotypes and epitope recognition during the prediabetic process in siblings of children with type I diabetes. Clin Exp Immunol 136:120-128
14. Mayr A, Schlosser M, Grober N, et al. (2007) GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 56:1527-1533
15. Pihoker C, Gilliam LK, Hampe CS, Lernmark A (2005) Autoantibodies in diabetes. Diabetes 54(Suppl 2):S52-S61
16. Ronkainen MS, Hoppu S, Korhonen S, et al. (2006) Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes. Eur J Endocrinol 155:633-642
17. Bonifacio E, Lampasona V, Bernasconi L, Ziegler AG (2000) Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes 49:202-208
18. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA (1997) Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710
19. Douek IF, Gillespie KM, Bingley PJ, Gale EA (2002) Diabetes in the parents of children with Type I diabetes. Diabetologia 45:495-501
20. Strebelow M, Schlosser M, Ziegler B, Rjasanowski I, Ziegler M (1999) Karlsburg type I diabetes risk study of a general population: frequencies and interactions of the four major type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia 42:661-670
21. Schlosser M, Strebelow M, Rjasanowski I, Kerner W, Wassmuth R, Ziegler M (2004) Prevalence of diabetes-associated autoantibodies in schoolchildren: the Karlsburg Type 1 Diabetes Risk Study. Ann N Y Acad Sci 1037:114-117
22. Schlosser M, Strebelow M, Wassmuth R, et al. (2002) The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab 87:2254-2261
23. Torn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ, Participating L (2008) Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51:846-852
24. Schlosser M, Mueller PW, Torn C, Bonifacio E, Bingley PJ (2010) Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia 53:2611-2620
25. Curnock RM, Reed CR, Rokni S, Broadhurst JW, Bingley PJ, Williams AJ (2012) Insulin autoantibody affinity measurement using a single concentration of unlabelled insulin competitor discriminates risk in relatives of patients with type 1 diabetes. Clin Exp Immunol 167:67-72
26. Schlosser M, Koczwara K, Kenk H, et al. (2005) In insulin-autoantibody- positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia 48:1830-1832
27. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E (2004) Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Investig 114:589-597
28. Siljander H, Harkonen T, Hermann R, et al. (2009) Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility. Diabetes Metab Res Rev 25:615-622
29. Krause S, Chmiel R, Bonifacio E, et al. (2012) IA-2 autoantibody affinity in children at risk for type 1 diabetes. Clin Immunol 145:224-229
30. Achenbach P, Lampasona V, Landherr U, et al. (2009) Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 52:1881-1888
31. De Grijse J, Asanghanwa M, Nouthe B, et al. (2010) Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia 53:517-524
32. Yu L, Boulware DC, Beam CA, et al. (2012) Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 35:1213-1218
33. Miao D, Guyer KM, Dong F, et al. (2013) GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes. Diabetes 62:4174-4178